Kinaxis (OTCMKTS:KXSCF – Get Free Report) will likely be releasing its results after the market closes on Wednesday, November 4th. Analysts expect Kinaxis to post earnings of $0.9640 per share and revenue of $152.01 million for the quarter.
Kinaxis Stock Down 3.6%
Shares of Kinaxis stock opened at $137.22 on Wednesday. The stock has a market cap of $3.72 billion and a PE ratio of 55.33. The business has a fifty day simple moving average of $127.99 and a 200-day simple moving average of $111.87. Kinaxis has a 12 month low of $84.70 and a 12 month high of $143.50.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on KXSCF. Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of Kinaxis in a research report on Monday, July 20th. BMO Capital Markets restated an “outperform” rating on shares of Kinaxis in a research report on Tuesday, August 4th. Four investment analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock currently has an average rating of “Buy”.
Get Our Latest Report on Kinaxis
Kinaxis Company Profile
Kinaxis Inc is a Canadian technology company that provides supply chain orchestration and planning software. Its solutions help organizations coordinate demand, supply, inventory, production, transportation and other supply chain activities across complex global operations.
The company’s primary platform, Kinaxis Maestro, is designed to support concurrent planning, supply and demand balancing, sales and operations planning, inventory management, control-tower visibility and scenario analysis.
See Also
- Five stocks we like better than Kinaxis
- Taiwan Semiconductor Flexes Pricing Power on AI’s Frontline
- Hidden in Plain Sight: 2 Earnings Winners Investors May Have Missed
- These 3 New ETFs Are Turning Heads—Are They Worth Buying?
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
